Initial roundtable discussion of groups involved in Adverse Events hosted by the FHIR Clinical Research Accelerator “Vulcan”.
Representatives from UNICOM T8.4 will “sit at the (round)table”.
The UNICOM Innovation Action has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 875299.
